Avadel Pharmaceuticals PLC
NASDAQ:AVDL

Watchlist Manager
Avadel Pharmaceuticals PLC Logo
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Watchlist
Price: 21.36 USD -0.14% Market Closed
Market Cap: 2.1B USD

Wall Street
Price Targets

AVDL Price Targets Summary
Avadel Pharmaceuticals PLC

Wall Street analysts forecast AVDL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVDL is 21.48 USD with a low forecast of 18.69 USD and a high forecast of 24.15 USD.

Lowest
Price Target
18.69 USD
13% Downside
Average
Price Target
21.48 USD
1% Upside
Highest
Price Target
24.15 USD
13% Upside
Avadel Pharmaceuticals PLC Competitors:
Price Targets
PBH
Prestige Consumer Healthcare Inc
29% Upside
NOVN
Novartis AG
4% Upside
COLL
Collegium Pharmaceutical Inc
2% Downside
4577
Daito Pharmaceutical Co Ltd
8% Downside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
35% Upside
1J5
Hyphens Pharma International Ltd
26% Upside
4521
Kaken Pharmaceutical Co Ltd
16% Upside
DHG
Dhg Pharmaceutical Joint-Stock Co
8% Upside

Revenue
Forecast

Revenue Estimate
Avadel Pharmaceuticals PLC

For the last 13 years the compound annual growth rate for Avadel Pharmaceuticals PLC's revenue is 14%. The projected CAGR for the next 4 years is 31%.

14%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Avadel Pharmaceuticals PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Avadel Pharmaceuticals PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVDL's stock price target?
Price Target
21.48 USD

According to Wall Street analysts, the average 1-year price target for AVDL is 21.48 USD with a low forecast of 18.69 USD and a high forecast of 24.15 USD.

What is Avadel Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
31%

For the last 13 years the compound annual growth rate for Avadel Pharmaceuticals PLC's revenue is 14%. The projected CAGR for the next 4 years is 31%.

Back to Top